Nov 30, 2025 05:16
MRK - Merck & Co., Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 95.1 3.06 (3.22%) | -0.09 (-0.1%) | -0.31 (-0.31%) | -0.64 (-0.65%) | 0.56 (0.59%) | 2.68 (2.81%) | -0.09 (-0.1%) | 0.63 (0.67%) |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Earnings & Ratios
- Basic EPS:
- 1.76
- Diluted EPS:
- 1.76
- Basic P/E:
- 55.7727
- Diluted P/E:
- 55.7727
- RSI(14) 1m:
- 45.52
- VWAP:
- 98.24
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Nov 28, 2025 03:50
Nov 26, 2025 16:00
Nov 24, 2025 18:00
Nov 21, 2025 15:48
Nov 19, 2025 14:37
Nov 19, 2025 13:13
Nov 18, 2025 17:42
Nov 17, 2025 16:00
Nov 13, 2025 09:25